{
  "docId": "019de074-59c8-7626-9039-436417019f39",
  "docSlug": "1770b23903474d178fa3f069f653cfbe",
  "documentTitle": "Hydrafacial | Results Presentation Deck | 32 slides",
  "authorId": "hydrafacial",
  "authorName": "BeautyHealth",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 5,
  "pageCount": 32,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "overcrowded",
  "nDataPoints": 11,
  "notes": "The slide uses a three-column layout to summarize key performance indicators and strategic progress.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-59c8-7626-9039-436417019f39/5",
  "deckHref": "/decks/019de074-59c8-7626-9039-436417019f39",
  "deckJsonHref": "/decks/019de074-59c8-7626-9039-436417019f39.json",
  "deckAnchorHref": "/decks/019de074-59c8-7626-9039-436417019f39#slide-5",
  "components": [
    {
      "bbox": {
        "x": 0.06,
        "y": 0.94
      },
      "kind": "disclaimer",
      "text": "1. Non-GAAP measure; refer to the disclaimer for a discussion of the definition of this measure and appendix for reconciliation to the most appropriate GAAP measure. 2. Excludes 2020 due to impact of COVID.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ccec7254-a332-4069-8f28-afc6a7ad63ab",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "x": 0.11,
        "y": 0.29
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "icon-grid",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "37b84d73-793c-49c3-b37b-3bce6e61c2b7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "x": 0.04,
        "y": 0.2
      },
      "kind": "list",
      "text": "Eight consecutive quarters of double-digit topline growth; $98.1mm Q4 2022 net sales (+26% YoY); $16.3mm Q4 2022 adjusted EBITDA (+92% YoY)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1c7b55c3-fd37-4342-a157-646233f1d201",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "x": 0.36,
        "y": 0.2
      },
      "kind": "list",
      "text": "Double-digit YoY growth across all regions; FY 2022 YoY growth: Americas +44%, APAC +24%, EMEA +46%, Global +41%; +48% 2018-2022 revenue CAGR",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7f12b6c9-4103-4189-8bac-2b7f7402e365",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "x": 0.67,
        "y": 0.2
      },
      "kind": "list",
      "text": "Outsized investment years now largely complete; Global infrastructure ready to scale; Positioned to drive profitable growth in 2023 and beyond",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "91bacfc7-e199-489a-8b49-1de0f822cb61",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "x": 0.05,
        "y": 0.86
      },
      "kind": "title",
      "text": "Continued momentum, confirms 2025 net sales and adjusted EBITDA margin targets",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3fccc944-6110-4d3c-86b4-e05cf59bdc99",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "x": 0.04,
        "y": 0.04
      },
      "kind": "title",
      "text": "BeautyHealth delivered strong top-line growth in 2022 and EBITDA in line with guidance",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f39b4f37-3543-4d24-8772-e28e6fe32646",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "436badbd-0bc2-4bb9-9a96-46e6671306a7",
      "evidence": "list/bullet: Outsized investment years now largely complete; Global infrastructure ready to scale; Positioned to drive profitable growth in 2023 and beyond",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 8,
      "from": 5,
      "beatId": "20ecf2a3-e87e-49b6-98be-94c19e12c76f",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Need",
      "beatSlug": "monroes-sequence-need",
      "evidence": "The company highlights its progress against its 5-point Master Plan and the need for continued growth.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}